| Location | Kankakee, Illinois |
| Website | csl.com |
Job Purpose:
The growing demand for Privigen and Hizentra requires an expansion of CSL's manufacturing capacity. To support this growth, immunoglobulin (Ig) production activities—from plasma thawing through sterile filling—will be incorporated into the new Building 45 at the CSL Kankakee (KAN) site to accommodate ZAPP Ig production. The new fill-finish facility is part of the Ig manufacturing expansion, known as Module (M) 7/8 at the CSL Behring Kankakee site.
This role will provide Quality oversight for the Commissioning and Qualification activities (C & Q). Partnering closely with colleagues in Project Quality, KAN Site Quality, Global Engineering, and TechOps across multiple manufacturing sites to ensure consistent application of quality principles, systems, and documentation standards.
The incumbent will focus on driving a standardized approach across projects, ensuring alignment in processes, documentation, and execution.
Responsible for building and maintaining strong collaborative relationships across all levels of the organization and with external contractors.
Responsibilities & Accountabilities:
Education:
Experience:
Competencies:
Working Conditions:
Travel Requirements:
The expected base salary range for this position at hiring is $91,000 - $120,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed location as of the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.
Different qualifications or responsibilities may apply based on local legal and/or educational requirements. Refer to local job documentation where applicable
#GTA
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.